Arun Sanyal, MBBS, MD
Disclosures: Consulting Fee-Eli Lilly and Company|Paid consultant-Echosens|Paid consultant-Abbott|Paid consultant-Promed|Paid consultant-Genfit|Paid consultant-Satellite Bio|Paid consultant-Corcept|Paid consultant-Arrowhead|Paid consultant-Boston Scientific|Paid consultant-Variant|Paid consultant-Cascade|Paid consultant-89Bio|Paid consultant-Astra Zeneca|Paid consultant-Alnylam Pharmaceuticals|Paid consultant-Regerenon Pharmaceuticals|Paid consultant-Boehringer Ingelheim|Paid consultant-Bristol Myers Squibb|Paid consultant-Genentech|Paid consultant-Gilead|Paid consultant-Histoindex|Paid consultant-Janssen|Paid consultant-Lipocine|Paid consultant-Madrigal Pharmaceuticals|Paid consultant-Merck|Paid consultant-Glaxo-Smith Kline|Paid consultant-Novartis|Paid consultant-Akero Therapeutics|Paid consultant-Novo Nordisk|Paid consultant-PathAI Diagnostics|Paid consultant-Histoindex|Paid consultant-Pfizer|Paid consultant-Poxel|Paid consultant-Salix|Paid consultant-Myovant Sciences|Paid consultant-MEDIAN Technologies|Paid consultant-Sequana Medical|Paid consultant-Surrozen|Paid consultant-Takeda Pharmaceuticals|Paid consultant-Terns Pharmaceuticals|Paid consultant-Zydus Pharmaceuticals|Grant or research support-Astra Zeneca|Grant or research support-Bristol Myers Squibb|Grant or research support-Gilead|Grant or research support-Intercept|Grant or research support-Malinckrodt|Grant or research support-Merck|Grant or research support-Ocelot Bio|Grant or research support-Novartis|Grant or research support-Salix|Royalties or Patent Beneficiary-Elsevier|Royalties or Patent Beneficiary-UpToDate|Stocks or stock options, excluding diversified mutual funds-Durect|Stocks or stock options, excluding diversified mutual funds-Genfit|Stocks or stock options, excluding diversified mutual funds-Tiziana|Stocks or stock options, excluding diversified mutual funds-Inversago - 10/22/2024

Arun J. Sanyal, M.D

 

Arun J. Sanyal, M.D

Virginia Commonwealth University

1200 East Broad Street P.O. Box 980341

Richmond, Virginia 23298-0341, United States

(804) 828-5066

arun.sanyal@vcuhealth.org

 

Arun J. Sanyal, M.D., is a Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University (VCU) Medical Center in Richmond, Virginia. He is ranked in the top 0.1% of all biomedical scientists and had about 12,000 citations in 2022. At VCU, he is currently the Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health.  Dr. Sanyal serves as Chairman of the NIH NASH Clinical Research Network, the NIMBLE consortium, and the Liver Forum for NASH and fibrosis. His research interests include all aspects of NAFLD and NASH as well as complications of end-stage liver disease. He has served on numerous advisory boards to pharmaceutical companies and the liver center at Yale University.  He chaired the hepatobiliary pathophysiology study section of the NIH and was a founding member of the Hepatology committee of the American Board of Internal Medicine.  He has also served as Secretary as well as President of the American Association for the Study of Liver Diseases.  Dr. Sanyal has authored more than 450 articles in publications such as Cell Metabolism, Nature Medicine, New England Journal of Medicine, Lancet, Gastroenterology, Hepatology, and the Journal of Infectious Diseases has an H-index of 154.  He has been continuously funded by the NIH since 1995 and is the principal investigator of four active NIH grants.  He is the recipient of the Distinguished Mentorship Award from the American Gastroenterological Association and the Distinguished Scientific Achievement Award from the American Liver Foundation in 2017 and the Distinguished Achievement Award from the AASLD in 2018.